In this interview with Life Science Sweden, Recipharm’s Senior Director, Science & Technology Officer discusses the pharmaceutical contract research, development and manufacturing landscape in Sweden and the growth in biopharmaceutical production over the last two years.
According to a report from the Swedish Agency for Growth Policy Analysis, contract research and manufacturing organisations (CRMOs) are among the fastest growing in terms of employee numbers and turnover.
The service sector’s increased growth can be attributed mainly to the fast pace of advancements in research.